IN-DATE
GWC-12325LG-FT: CSI ViperWire Advance Guidewire 0.012" x 325cm
Sign in to add this product to your favorites!
| Price: | $15.00 per box of 5 |
|---|---|
| Quantity: | |
| In Stock: | 6 box of 5 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 10 hours 27 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
Related Items
QUICK VIEW
| GWC-12325LG-FT - Size: 0.012" $3.00 EACH CSI ViperWire Advance Guidewire 0.012" x 325cm Expired Units in stock: 125 | Order Qty |
QUICK VIEW
| GWC-12325LG-FLP - Size: 0.012" $3.00 EACH CSI ViperWire Advance Guidewire 0.012" x 325cm Expired Units in stock: 100 | Order Qty |
QUICK VIEW
| GWC-12325LG-FLP - Size: 0.012" $15.00 per box of 5 CSI ViperWire Advance Guidewire 0.012" x 325cm Expired Units in stock: 18 box of 5 | Order Qty |
Additional Details
Abbott CSI ViperWire Advance Coronary Guide Wire
To be used exclusively with CSI Diamondback 360 Coronary Orbital Atherectomy System
AccessGUDID Info
- FDA Product Code: MCX
- FDA Product Code Name: Catheter, Coronary, Atherectomy
- GMDN Term Code: 35094
- GMDN Term Name: Cardiac/peripheral vascular guidewire, single-use
- GMDN Term Description: A long, thin, sterile wire intended to be percutaneously placed into the cardiac vasculature (ventricles or coronary vessels) to function as a guide for the introduction, positioning, and/or operation of a device (e.g., catheter, pacing lead); it may also be used in the peripheral vasculature. It may be made of metal (e.g., stainless steel, Nitinol), or polymer and/or glass materials to provide MRI-compatibility, with or without coating, and is available in a variety of distal tip designs. It is used for various diagnostic and interventional procedures, and may include devices used to facilitate manipulation (e.g., torque device). This is a single-use device.
Manufacturer
Cardiovascular Systems, Inc. (CSI), now a part of Abbott, specialized in innovative solutions for the treatment of peripheral and coronary artery disease through its proprietary orbital atherectomy systems. CSI’s flagship technologies include the Diamondback 360® Peripheral Orbital Atherectomy System and the Diamondback 360® Coronary Orbital Atherectomy System, both designed to modify calcified plaque and improve vessel compliance prior to stent placement or balloon angioplasty.
These systems use a diamond-coated crown that orbits within the vessel, sanding away plaque while preserving healthy tissue and facilitating better device delivery. CSI’s focus on challenging arterial disease—particularly in heavily calcified lesions—made it a valuable addition to Abbott’s vascular portfolio following its acquisition in 2023, further expanding minimally invasive treatment options for complex cardiovascular cases.
